» Articles » PMID: 22466823

Associations of Insulin Resistance and Glycemic Control with the Risk of Kidney Stones

Overview
Journal Intern Med
Specialty General Medicine
Date 2012 Apr 3
PMID 22466823
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The associations of insulin resistance and glycemic control with the risk of kidney stones were explored.

Methods: Generally healthy Japanese (n=2,171) who visited Saiseikai Central Hospital (Tokyo, Japan) for a health check were included in a cross-sectional study. We calculated odds ratios (OR) of having kidney stones in terms of four measures: fasting serum insulin, homeostasis model assessment of insulin resistance (HOMA-IR), fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c), adjusting for possible risk factors for kidney stones.

Results: Fasting serum insulin and HOMA-IR were non-significantly associated with the risk of kidney stones, whereas FPG and HbA1c were significantly associated. Compared with those with an FPG of <100 mg/dL, the ORs in those with an FPG of 100 to <126 mg/dL and ≥126 mg/dL were 1.38 (95% confidence interval [CI] =0.95-2.00) and 1.83 (95% CI =1.09-3.06) (p for trend =0.016). In relation to those with an HbA1c of <5.5%, the ORs in those with an HbA1c of 5.5 to <6.0%, 6.0% to <6.5% and ≥6.5% were 1.16 (95% CI =0.76-1.79), 1.25 (95% CI =0.70-2.23) and 1.98 (95% CI =1.11-3.52), respectively (p for trend =0.027). The significant associations between glycemic control measures and the risk of kidney stones were preserved even after the adjustment for factors related to insulin resistance.

Conclusion: Glycemic control could be an independent risk factor for kidney stones.

Citing Articles

When acute myocardial infarction meets renal abscess: Case report and literature review.

Zhu X, Shu H, Han S, Li J, Su H, Li Q Medicine (Baltimore). 2025; 103(47):e40655.

PMID: 39809180 PMC: 11596588. DOI: 10.1097/MD.0000000000040655.


Insulin Resistance in Hypercalciuric Calcium Kidney Stone Patients.

Prochaska M, Adeola G, Vetter N, Mirmira R, Coe F, Worcester E Kidney Med. 2024; 6(12):100922.

PMID: 39634328 PMC: 11615144. DOI: 10.1016/j.xkme.2024.100922.


Elucidating shared biomarkers and pathways in kidney stones and diabetes: insights into novel therapeutic targets and the role of resveratrol.

Shen S, Wei J, Kang W, Wang T J Transl Med. 2023; 21(1):491.

PMID: 37480086 PMC: 10360253. DOI: 10.1186/s12967-023-04356-4.


Protection of Liver Functions and Improvement of Kidney Functions by Twelve Weeks Consumption of Cuban Policosanol (Raydel) with a Decrease of Glycated Hemoglobin and Blood Pressure from a Randomized, Placebo-Controlled, and Double-Blinded Study....

Cho K, Kim J, Komatsu T, Uehara Y Life (Basel). 2023; 13(6).

PMID: 37374102 PMC: 10301011. DOI: 10.3390/life13061319.


Prevalence and risk factors of kidney stone disease in population aged 40-70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran.

Moftakhar L, Jafari F, Ghoddusi Johari M, Rezaeianzadeh R, Hosseini S, Rezaianzadeh A BMC Urol. 2022; 22(1):205.

PMID: 36536352 PMC: 9764470. DOI: 10.1186/s12894-022-01161-x.